Use of Edoxaban for the Treatment of Heparin-Induced Thrombocytopenia
المؤلفون المشاركون
Yoshida, Shohei
Tanaka, Hiroyuki
Kanamoto, Ryo
Hiromatsu, Shinichi
Anegawa, Tomoyuki
Sakurai, Kanako
Shintani, Yusuke
Otsuka, Hiroyuki
Tobinaga, Satoru
المصدر
Case Reports in Vascular Medicine
العدد
المجلد 2020، العدد 2020 (31 ديسمبر/كانون الأول 2020)، ص ص. 1-4، 4ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2020-09-07
دولة النشر
مصر
عدد الصفحات
4
التخصصات الرئيسية
الملخص EN
Heparin-induced thrombocytopenia (HIT) is a life-threatening adverse drug reaction of heparin therapy, which increases a patient’s risk of developing venous and/or arterial thromboembolism.
HIT should be treated through discontinuation of heparin and administration of nonheparin anticoagulants such as argatroban.
For long-term anticoagulation, parenteral nonheparin anticoagulants are generally converted to oral treatment with a vitamin K antagonist such as warfarin.
Although administration of warfarin is recommended to overlap with a nonheparin anticoagulant for a minimum of 5 days, overlapping with argatroban and warfarin presents high risks of bleeding.
We describe a case of HIT treated with edoxaban.
A 78-year-old man underwent surgery for esophageal cancer and was administered heparin perioperatively.
After surgery, he was diagnosed with HIT and venous thromboembolism.
We immediately stopped heparin and initiated parenteral argatroban.
The patient was subsequently started on edoxaban without any overlap between the two drugs.
The treatment was successful.
The treatment of edoxaban following argatroban for HIT could reduce bleeding complications and shorten the length of hospital stay.
To the best of our knowledge, this is the first report of the use of edoxaban for HIT treatment.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Kanamoto, Ryo& Hiromatsu, Shinichi& Anegawa, Tomoyuki& Sakurai, Kanako& Yoshida, Shohei& Shintani, Yusuke…[et al.]. 2020. Use of Edoxaban for the Treatment of Heparin-Induced Thrombocytopenia. Case Reports in Vascular Medicine،Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1151937
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Kanamoto, Ryo…[et al.]. Use of Edoxaban for the Treatment of Heparin-Induced Thrombocytopenia. Case Reports in Vascular Medicine No. 2020 (2020), pp.1-4.
https://search.emarefa.net/detail/BIM-1151937
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Kanamoto, Ryo& Hiromatsu, Shinichi& Anegawa, Tomoyuki& Sakurai, Kanako& Yoshida, Shohei& Shintani, Yusuke…[et al.]. Use of Edoxaban for the Treatment of Heparin-Induced Thrombocytopenia. Case Reports in Vascular Medicine. 2020. Vol. 2020, no. 2020, pp.1-4.
https://search.emarefa.net/detail/BIM-1151937
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-1151937
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر